Endocrine Toxicities of Antineoplastic Therapy.


Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
14 Jan 2021
Historique:
received: 29 12 2020
accepted: 12 01 2021
entrez: 20 1 2021
pubmed: 21 1 2021
medline: 21 1 2021
Statut: epublish

Résumé

In recent years, the prognosis of many solid tumors has improved markedly thanks to new treatment strategies, including tyrosine kinase inhibitors (TKIs) and immunotherapy [...].

Identifiants

pubmed: 33466843
pii: cancers13020294
doi: 10.3390/cancers13020294
pmc: PMC7830439
pii:
doi:

Types de publication

Editorial

Langues

eng

Références

JAMA Oncol. 2018 Feb 1;4(2):173-182
pubmed: 28973656
Eur J Endocrinol. 2021 Jan;184(1):R29-R40
pubmed: 33112294
J Immunother Cancer. 2018 Jan 23;6(1):8
pubmed: 29357948
Ann Endocrinol (Paris). 2018 Oct;79(5):574-582
pubmed: 30174137
N Engl J Med. 2006 May 11;354(19):2006-13
pubmed: 16687713
N Engl J Med. 2005 Jul 14;353(2):172-87
pubmed: 16014887
Cochrane Database Syst Rev. 2016 Feb 02;2:CD005540
pubmed: 26830050
Eur J Endocrinol. 2014 Feb 01;170(2):R43-55
pubmed: 24154684
Bone. 2011 Aug;49(2):281-9
pubmed: 21550432
Ann Endocrinol (Paris). 2018 Oct;79(5):591-595
pubmed: 30056975
Climacteric. 2019 Dec;22(6):553-557
pubmed: 30380961
Metabolism. 2018 Jan;78:141-154
pubmed: 28993227
Calcif Tissue Int. 2018 Feb;102(2):251-264
pubmed: 29353450
Pituitary. 2016 Feb;19(1):82-92
pubmed: 26186958
Endocr Relat Cancer. 2012 Apr 10;19(2):R21-33
pubmed: 22241718
J Clin Oncol. 2018 Jul 1;36(19):1994-2001
pubmed: 29620997
Clin Immunol. 2020 Apr;213:108377
pubmed: 32135278
Front Oncol. 2020 Dec 01;10:582394
pubmed: 33335854
N Engl J Med. 2015 Jul 2;373(1):23-34
pubmed: 26027431
Drug Metab Rev. 2019 Nov;51(4):562-569
pubmed: 31718371
J Endocrinol Invest. 2019 Jul;42(7):745-756
pubmed: 30471004
Science. 2015 Apr 3;348(6230):69-74
pubmed: 25838375
J Clin Endocrinol Metab. 2013 Apr;98(4):1333-42
pubmed: 23450053
Endocrine. 2020 Mar;67(3):597-604
pubmed: 31679139
Nat Immunol. 2013 Oct;14(10):1014-22
pubmed: 24048123
Front Oncol. 2020 May 19;10:779
pubmed: 32509580
Ann Oncol. 2018 Jan 1;29(1):84-91
pubmed: 29228097
Crit Rev Oncol Hematol. 2019 Sep;141:23-35
pubmed: 31202955
Ann Oncol. 2017 Jul 1;28(suppl_4):iv119-iv142
pubmed: 28881921
Cancer Med. 2017 Aug;6(8):1923-1929
pubmed: 28719055

Auteurs

Giulia Puliani (G)

Oncological Endocrinology Unit, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.
Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy.

Marialuisa Appetecchia (M)

Oncological Endocrinology Unit, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.

Classifications MeSH